Home > Insider Trading > Filing (0001209191-17-067149)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021412	W Jack Schuler	12544 High Bluff Drive, Suite 200 San Diego CA 92130		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-20	3,500	$44.40	3,365,553	No	4	S	Direct
Common Stock	Disposition	2017-12-21	500	$46.00	3,365,053	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The weighted average sale price for these transactions was $44.40 per share, with a range of $43.00 to $46.00. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $46.00 per share, with a range of $46.00 to $46.02. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse, 1,053,628 shares are held indirectly by the Schuler Family Foundation and 523,524 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by his spouse, the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.